Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis (PEARL 2)
This study has been completed.
Study NCT00598442   Information provided by Affymax

First Received on January 10, 2008.   Last Updated on February 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Renal Failure
Chronic Kidney Disease
Anemia
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency
Renal Insufficiency, Chronic
More general conditions related to this trial
Hematologic Diseases
Urologic Diseases
Interventions listed in this trial
peginesatide
Darbepoetin alfa
Additional drug interventions recognized in this trial
Hematinics
More general drug interventions related to this trial
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Affymax
Takeda Pharmaceutical Company Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services